Skip to main content
. 2022 Apr 2;22:142. doi: 10.1186/s12935-022-02561-7

Fig. 3.

Fig. 3

The molecular mechanisms of resveratrol co-treatment during colorectal cancer treatment by 5-fluorouracil (5-FU) chemotherapeutic agent. Resveratrol exerts the synergistic anti-tumoral effects through increments in oxidant and apoptosis activities, and reduction in inflammatory effects. ↑↑synergistically increased by 5-FU plus resveratrol compared to 5-FU alone; ↑↑synergistically decreased by 5-FU plus resveratrol compared to 5-FU alone; ↓decreased by 5-FU plus resveratrol compared to 5-FU alone; Bcl-xL, B-cell lymphoma-extra large; BAX, Bcl-2-associated X protein; GPx, glutathione peroxidase; IL-6, interleukin 6; IKK, IκBα kinase; LPO, lipid peroxidation; ROS, reactive oxygen species; NF-κB, nuclear factor-kappa B; COX-2, cyclooxygenase-2; TNF-α, tumor necrosis factor alpha.; MMP-9, matrix metalloproteinase-9